In this article, we will discuss Alitretinoin (Clinical Studies-7). So, let’s get started.
Study 2 was an international study with a planned enrollment of 270 patients. Patients were treated topically twice a day with Alitretinoin gel or a matching vehicle for 12 weeks. The study was stopped early because of positive interim results in the initial 82 patient data set. Responses to Alitretinoin gel were seen both in previously untreated patients and in patients with prior systemic and/or topical KS treatment.